Home » Topics » BioWorld Science

BioWorld Science
RSS

CAR-iNKT cells safe and active in neuroblastoma patients

Oct. 7, 2019

GlaxoSmithKline initiates phase I study of GSK-2904545A vaccine candidate

Oct. 7, 2019

First-in-human study of apramycin

Oct. 7, 2019

Results presented from phase III SANET-ep study of surufatinib

Oct. 7, 2019

Symphogen presents early clinical data for Sym-015 in advanced solid tumors

Oct. 7, 2019

Development of novel sclerostin-resistant mouse model of T1D

Oct. 7, 2019

Shanghai Fochon Pharmaceutical, Fochon Pharmaceuticals patent TRK inhibitors

Oct. 7, 2019

Phase III data demonstrates equivalence between SB8 and bevacizumab in terms of best ORR

Oct. 7, 2019

Identification of PDE10A inhibitors with potential application in schizophrenia

Oct. 7, 2019

Deinove studies DNV-3837 in phase II for C. difficile infection

Oct. 4, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...